Brief Description
This study seeks to explore taVNS as a potential, novel treatment for children with frequently relapsing nephrotic syndrome (FRNS).
Estimated Enrollment
30 patients
Estimated End Date
08/01/2025
Trial is for people with
Frequently relapsing nephrotic syndrome (FRNS), minimal change disease (MCD), or focal segmental glomerulosclerosis (FSGS)
Study Goal
The goal of this study is to investigate the efficacy of taVNS in the treatment of FRNS in children.
What is involved for the patient?
If eligible, patients will be asked to use the device twice daily for ten minutes and monitor urine at home with a urine dipstick. ...
About the drug or intervention
The device used is the Roscoe Medical TENS 7000, a commercially available electrical pulse generator, and an ear clip to be placed at ...
